A study of the longitudinal changes in multiple cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers on converter and non‐converter Alzheimer's disease subjects with consideration for their amyloid beta status

INTRODUCTION: This study aims to determine whether newly introduced biomarkers Visinin‐like protein‐1 (VILIP‐1), chitinase‐3‐like protein 1 (YKL‐40), synaptosomal‐associated protein 25 (SNAP‐25), and neurogranin (NG) in cerebrospinal fluid are useful in evaluating the asymptomatic and early symptoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Morar, Ulyana, Izquierdo, Walter, Martin, Harold, Forouzannezhad, Parisa, Zarafshan, Elaheh, Unger, Elona, Bursac, Zoran, Cabrerizo, Mercedes, Barreto, Armando, Vaillancourt, David E., DeKosky, Steven T., Loewenstein, David, Duara, Ranjan, Adjouadi, Malek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Cerebrospinal Fluid Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865744/
https://www.ncbi.nlm.nih.gov/pubmed/35229014
http://dx.doi.org/10.1002/dad2.12258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865744/
https://www.ncbi.nlm.nih.gov/pubmed/35229014
http://dx.doi.org/10.1002/dad2.12258

Ejemplares similares